10055 Barnes Canyon Road
San Diego, CA 92121
Tel: (619) 353-0300
About Element Biosciences
At Element Biosciences, our mission is to empower the scientific community with more freedom and flexibility to accelerate our collective impact on humanity. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality. Founded in 2017, our headquarters is located in San Diego, California, with additional operations located in the San Francisco Bay area.
31 articles with Element Biosciences
Element Biosciences and Jumpcode Genomics Partner to Validate Jumpcode’s CRISPRclean® Technology on Element’s AVITI™ System for a Broad Set of Genomic Applications
Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics that validates Jumpcode's CRISPRclean technology on Element’s AVITI System.
Element Biosciences Partners with Watchmaker Genomics to Validate Watchmaker Library Preparation Kits on Element’s AVITI™ System
Element Biosciences, Inc. today announced a partnership with Watchmaker Genomics demonstrating the value and performance of Watchmaker’s DNA and RNA Library Prep Kits on Element’s AVITI System.
Element Biosciences Partners with QIAGEN to Validate a Selection of QIAseq Targeted Library Construction Chemistries on Element’s AVITI™ System
Element Biosciences, Inc. today announced a partnership with QIAGEN to validate its leading NGS library prep and target enrichment offerings on the AVITI System.
Element Biosciences Partners with New England Biolabs® to Launch New NEBNext® Ultra™ II Kits Specifically Designed for the Element AVITI™ System
Element Biosciences, Inc. today announced a partnership with New England Biolabs (NEB®) to commercially develop and launch products to enable compatibility of the NEBNext Ultra II portfolio with the Element AVITI System.
Element Biosciences Partners with Agilent Technologies to Validate SureSelect™ Target Enrichment Panels on Element’s AVITI™ System
Element Biosciences Inc. today announced a partnership with Agilent Technologies demonstrating integration of Element’s AVITI System with Agilent Technologies’ industry-leading SureSelect target enrichment panels, providing customers greater access to these genomic tools.
Element Biosciences New AVITI System Shows Seamless Compatibility and High Performance with KAPA Library Preparation Kits in Multiple NGS Applications
Element Biosciences, Inc. today announced a key technical milestone using the Roche KAPA HyperPlus and KAPA EvoPlus library preparation and target enrichment kits in microbial whole genome, human whole genome, and human whole exome sequencing applications.
Element Biosciences Strengthens Leadership Team to Advance Novel Applications Development and Scientific Affairs
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointment of Shawn Levy, PhD, as Senior Vice President of Applications and Scientific Affairs.
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced that the company has closed its acquisition of Loop Genomics, a long-read solutions company that enables short-read sequencers to obtain long range information.
Element Biosciences Bolsters Leadership Team to Advance Development and Commercialization of DNA Sequencing Platform
Brian Stolz Joins as Chief People Officer, Diana King as VP of Customer Support, and Jordan Neysmith as VP of Engineering
Life sciences news sometimes flies under the radar. So here’s a look at a few stories you may have missed.
Element Biosciences , developer of a new and disruptive DNA sequencing platform, today announced the close of a $276 million Series C financing.